Ensign Peak Advisors’s IN8bio INAB Stock Holding History

Ensign Peak Advisors’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,639	Closed	-$224K	–	1715
2024 Q3	$224K	Sell	27,639 -9,637	-26%	-$175K	﹤0.01%	1689
2024 Q2	$947K	Hold	37,276	–	–	﹤0.01%	1316
2024 Q1	$1.32M	Hold	37,276	–	–	﹤0.01%	1143
2023 Q4	$1.54M	Buy	37,276 +21,608	+138%	+$691K	﹤0.01%	1058
2023 Q3	$489K	Hold	15,668	–	–	﹤0.01%	1597
2023 Q2	$724K	Buy	15,668 +13,334	+571%	+$834K	﹤0.01%	1481
2023 Q1	$91K	Hold	2,334	–	–	﹤0.01%	1757
2022 Q4	$162K	Hold	2,334	–	–	﹤0.01%	1754
2022 Q3	$141K	Hold	2,334	–	–	﹤0.01%	1999
2022 Q2	$170K	Hold	2,334	–	–	﹤0.01%	1843
2022 Q1	$243K	Hold	2,334	–	–	﹤0.01%	1822
2021 Q4	$307K	Buy	+2,334	New	+$461K	﹤0.01%	1809

Other funds holding INAB

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ensign Peak Advisors's INAB Position: Q4 2024 in Review

Ensign Peak Advisors sold out of IN8bio (INAB) in Q4 2024, closing a stake of 27,639 shares — an estimated $224K sold.

Ensign Peak Advisors first reported a position in INAB in Q4 2021 and held it in 12 quarters. The position peaked at $1.54M in Q4 2023. 24 funds tracked by Wall St. Rank hold INAB as of Q4 2024.

Ensign Peak Advisors reported no remaining IN8bio position as of Q4 2024 after selling out during the quarter.
Ensign Peak Advisors sold 27,639 IN8bio shares in Q4 2024, an estimated $224K.
Ensign Peak Advisors first reported a position in IN8bio in Q4 2021 and held it in 12 quarters.
Ensign Peak Advisors's IN8bio position peaked at $1.54M in Q4 2023.
24 funds tracked by Wall St. Rank held IN8bio as of Q4 2024.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.